Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience

Area of Science:

• Vaccinology
• Global Health
• Public Health Policy

Background:

• Delayed introduction of Haemophilus influenzae type b (Hib) vaccine in developing countries.
• Significant increase in Hib vaccine adoption observed between 2005 and 2009, especially in GAVI-eligible nations.

Purpose of the Study:

• To review the strategy implemented by the Hib Initiative.
• To identify lessons learned from the Hib Initiative's efforts to accelerate vaccine adoption.
• To propose a model for accelerating the uptake of other new vaccines.

Main Methods:

• Review of the strategy and operational model of the Hib Initiative.
• Analysis of factors contributing to increased Hib vaccine adoption.
• Case study approach focusing on GAVI-eligible countries.

Main Results:

• The Hib Initiative, funded by the GAVI Alliance, played a crucial role in accelerating Hib vaccine adoption.
• Evidence-informed decision-making processes were central to the initiative's success.
• Factors such as financial support and strategic guidance facilitated rapid uptake.

Conclusions:

• The Hib Initiative's strategy provides a successful model for overcoming barriers to new vaccine introduction.
• Lessons learned can inform future public health interventions for vaccine rollout.
• Accelerated adoption of new vaccines is achievable with targeted support and strategic planning.